Significant Role and Mechanism of MicroRNA-143-3p/KLLN Axis in the Development of Coronary Heart Disease

Overview

Journal Am J Transl Res

Specialty General Medicine

Date 2019 Jul 18

PMID 31312371

Citations 7

Authors

Huadong Liu

Wei Xiong

Feng Liu

Feng Lin

Junbo He

Cheng Liu

Yaowang Lin

Shaohong Dong

Affiliations

Soon will be listed here.

Abstract

Cardiovascular disease predominantly includes coronary heart disease (CHD) and stroke, results in high morbidity and mortality. MicroRNA-143-3p (miR-143-3p) is a tumor suppressor and is involved in many cancers. However, the role and mechanism of miR-143-3p in coronary heart disease is still unclear. In this study, we identified that miR-143-3p was up-regulated in rabbit CHD model. The results of TargetScan and the dual luciferase reporter assay indicated that KLLN (killin, p53 regulated DNA replication inhibitor) was a direct target of miR-143-3p. Besides, we revealed that KLLN was down-regulated in rabbit coronary heart disease model. In addition, we found that the related-markers of CHD such as TC (total cholesterol), TG (triglyceride), and LDLC (low-density lipoprotein cholesterol) in the model group were significantly increased than that in the control group. And compared with the model group, miR-143-3p inhibitor significantly reduced TC, TG, LDLC expression, while miR-143-3p mimic further increased the expression of TC, TG, and LDLC. We next found that miR-143-3p mimic promoted cell viability and migration of vascular smooth muscle cells, inhibited apoptosis; and these changes were reversed by KLLN-plasmid. And miR-143-3p inhibitor had the counter effects. Our study provided a new target for the treatment of CHD and deserves further study.

Citing Articles

Cardiovascular Disease-Associated MicroRNAs as Novel Biomarkers of First-Trimester Screening for Gestational Diabetes Mellitus in the Absence of Other Pregnancy-Related Complications.

Hromadnikova I, Kotlabova K, Krofta L Int J Mol Sci. 2022; 23(18).

PMID: 36142536 PMC: 9501303. DOI: 10.3390/ijms231810635.

lncRNA MALAT1/miR-143 axis is a potential biomarker for in-stent restenosis and is involved in the multiplication of vascular smooth muscle cells.

Cao C, Zhen W, Yu H, Zhang L, Liu Y Open Life Sci. 2022; 16(1):1303-1312.

PMID: 35005241 PMC: 8691378. DOI: 10.1515/biol-2021-0126.

circAMOTL1L Suppresses Renal Cell Carcinoma Growth by Modulating the miR-92a-2-5p/KLLN Pathway.

Gao L, Shao X, Yue Q, Wu W, Yang X, He X Oxid Med Cell Longev. 2021; 2021:9970272.

PMID: 34646428 PMC: 8505055. DOI: 10.1155/2021/9970272.

Constitutive activation of the NEAT1/miR-22-3p/Ltb4r1 signaling pathway in mice with myocardial injury following acute myocardial infarction.

Wang L, Wang L, Wang Q Aging (Albany NY). 2021; 13(11):15307-15319.

PMID: 34081624 PMC: 8221362. DOI: 10.18632/aging.203089.

Comparison of efficacy between sequential ventilation and conventional invasive mechanical ventilation in the treatment of pulmonary hypertension complicated with respiratory failure.

Zhu Y, Ke K, Dai Z, Tang H, Xu Q, Guo T Am J Blood Res. 2020; 10(5):231-239.

PMID: 33224567 PMC: 7675131.

References

Yanni A . The laboratory rabbit: an animal model of atherosclerosis research. Lab Anim. 2004; 38(3):246-56. DOI: 10.1258/002367704323133628. View

Cho Y, Liang P . Killin is a p53-regulated nuclear inhibitor of DNA synthesis. Proc Natl Acad Sci U S A. 2008; 105(14):5396-401. PMC: 2291080. DOI: 10.1073/pnas.0705410105. View

Chen X, Guo X, Zhang H, Xiang Y, Chen J, Yin Y . Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene. 2009; 28(10):1385-92. DOI: 10.1038/onc.2008.474. View

Cordes K, Sheehy N, White M, Berry E, Morton S, Muth A . miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature. 2009; 460(7256):705-10. PMC: 2769203. DOI: 10.1038/nature08195. View

Krol J, Loedige I, Filipowicz W . The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010; 11(9):597-610. DOI: 10.1038/nrg2843. View

Chen Z, Zeng H, Guo Y, Liu P, Pan H, Deng A . miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc. J Exp Clin Cancer Res. 2010; 29:151. PMC: 2999592. DOI: 10.1186/1756-9966-29-151. View

Jordan S, Kruger M, Willmes D, Redemann N, Wunderlich F, Bronneke H . Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat Cell Biol. 2011; 13(4):434-46. DOI: 10.1038/ncb2211. View

Katz M, Fargnoli A, Tomasulo C, Pritchette L, Bridges C . Model-specific selection of molecular targets for heart failure gene therapy. J Gene Med. 2011; 13(10):573-86. PMC: 3680133. DOI: 10.1002/jgm.1610. View

Duranthon V, Beaujean N, Brunner M, Odening K, Navarrete Santos A, Kacskovics I . On the emerging role of rabbit as human disease model and the instrumental role of novel transgenic tools. Transgenic Res. 2012; 21(4):699-713. DOI: 10.1007/s11248-012-9599-x. View

10.

Fang R, Xiao T, Fang Z, Sun Y, Li F, Gao Y . MicroRNA-143 (miR-143) regulates cancer glycolysis via targeting hexokinase 2 gene. J Biol Chem. 2012; 287(27):23227-35. PMC: 3391126. DOI: 10.1074/jbc.M112.373084. View

11.

Wang Y, Radhakrishnan D, He X, Peehl D, Eng C . Transcription factor KLLN inhibits tumor growth by AR suppression, induces apoptosis by TP53/TP73 stimulation in prostate carcinomas, and correlates with cellular differentiation. J Clin Endocrinol Metab. 2013; 98(3):E586-94. PMC: 3678149. DOI: 10.1210/jc.2012-3490. View

12.

Wang Y, He X, Yu Q, Eng C . Androgen receptor-induced tumor suppressor, KLLN, inhibits breast cancer growth and transcriptionally activates p53/p73-mediated apoptosis in breast carcinomas. Hum Mol Genet. 2013; 22(11):2263-72. DOI: 10.1093/hmg/ddt077. View

13.

Nizialek E, Peterson C, Mester J, Downes-Kelly E, Eng C . Germline and somatic KLLN alterations in breast cancer dysregulate G2 arrest. Hum Mol Genet. 2013; 22(12):2451-61. PMC: 3858115. DOI: 10.1093/hmg/ddt097. View

14.

Peng X . Transgenic rabbit models for studying human cardiovascular diseases. Comp Med. 2013; 62(6):472-9. PMC: 3527751. View

15.

Pham H, Rodriguez C, Donald G, Hertzer K, Jung X, Chang H . miR-143 decreases COX-2 mRNA stability and expression in pancreatic cancer cells. Biochem Biophys Res Commun. 2013; 439(1):6-11. PMC: 3789599. DOI: 10.1016/j.bbrc.2013.08.042. View

16.

Wimmer N, Scirica B, Stone P . The clinical significance of continuous ECG (ambulatory ECG or Holter) monitoring of the ST-segment to evaluate ischemia: a review. Prog Cardiovasc Dis. 2013; 56(2):195-202. PMC: 4349575. DOI: 10.1016/j.pcad.2013.07.001. View

17.

Chang R, Yang H, Fang F, Xu J, Yang L . MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase. Hepatology. 2014; 60(4):1251-63. DOI: 10.1002/hep.27221. View

18.

Han T, Hur K, Xu G, Choi B, Okugawa Y, Toiyama Y . MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1. Gut. 2014; 64(2):203-14. PMC: 4384419. DOI: 10.1136/gutjnl-2013-306640. View

19.

Liu G, Jiang C, Li D, Wang R, Wang W . MiRNA-34a inhibits EGFR-signaling-dependent MMP7 activation in gastric cancer. Tumour Biol. 2014; 35(10):9801-6. DOI: 10.1007/s13277-014-2273-6. View

20.

Zhu L, Jiang J, Zhu X, Wang T, Chen X, Luo Q . Knockdown of Aurora-B inhibits osteosarcoma cell invasion and migration via modulating PI3K/Akt/NF-κB signaling pathway. Int J Clin Exp Pathol. 2014; 7(7):3984-91. PMC: 4129010. View